Holen Sie sich die Stockscreener-App
10.13
3.79%
0.37
Handel nachbörslich:
10.23
0.10
+0.99%
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Ginkgo Bioworks Holdings Inc. Stock Analysis and ForecastFree Investment Case Studies - Jammu Links News
What drives Ginkgo Bioworks Holdings Inc. stock priceConsistent high-yield stocks - Jammu Links News
Ginkgo Bioworks launches cost-effective ADME profiling service By Investing.com - Investing.com Canada
Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors - MarketScreener
Ginkgo Disrupts Drug Discovery Market with US-Based ADME Service Matching Chinese Prices - Stock Titan
Ginkgo Bioworks Holdings, Inc. (DNA) Outperforms Broader Market: What You Need to Know - MSN
Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Share Price Not Quite Adding Up - 富途牛牛
When the Price of (DNA) Talks, People Listen - news.stocktradersdaily.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why - sharewise.com
Ginkgo Bioworks (DNA) Shares Soar 5.29% on Q2 Earnings - AInvest
Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock? - MSN
(DNA) On The My Stocks Page - news.stocktradersdaily.com
Ginkgo Bioworks Holdings, Inc.(NYSE: DNA) added to Russell Small Cap Comp Value Index - MarketScreener
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves 1.41%: What You Should Know - MSN
Is Ginkgo Bioworks Holdings, Inc. overvalued or undervalued? - MarketsMojo
Lobbying Update: $10,000 of GINKGO BIOWORKS lobbying was just disclosed - Nasdaq
Ginkgo Bioworks Holds Annual Shareholder Meeting, Elects Directors - TipRanks
5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io
Ginkgo Bioworks (DNA) Sees 5.4% Increase in Stock Price | DNA Stock News - GuruFocus
Where are the Opportunities in (DNA) - news.stocktradersdaily.com
Ginkgo Bioworks: Hedge Funds Pull Back and Other Important Updates - TradingView
Squarepoint Ops LLC Has $417,000 Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
From Promise to Peril: The Downfall of Ginkgo Bioworks - TradingView
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
Top 5 CRISPR Companies To Invest In (June 2025) - Securities.io
Northern Trust Corp Buys 9,791 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and Elanco Animal Health (ELAN) - The Globe and Mail
(DNA) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Millennium Management LLC Has $6.58 Million Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care - Quantisnow
Ginkgo Bioworks: Cost-Cutting Efforts Aren't Enough (NYSE:DNA) - Seeking Alpha
Major Moves And Shakes In Health Care Sector - Finimize
Sector Update: Health Care - marketscreener.com
Ginkgo Bioworks announces CFO transition - MSN
Ginkgo Bioworks (DNA) Announces CFO Transition - GuruFocus
Ginkgo Bioworks CFO Mark Dmytruk to Resign, Steven Coen Appointed as New Finance Chief - marketscreener.com
Ginkgo Bioworks Announces Appointment Of Steven Coen As Chief Financial Officer - marketscreener.com
Charles River Laboratories (CRL): Leadership Change at Ginkgo Bi - GuruFocus
Charles River Laboratories (CRL): Leadership Change at Ginkgo Bioworks | CRL Stock News - GuruFocus
Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer - StreetInsider
Ginkgo Bioworks Promotes 30-Year Finance Expert to CFO Role, Maintains 2026 EBITDA Target - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is a favorite amongst institutional investors who own 56% - Yahoo Finance
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should Know - MSN
Twist Bioscience and Ginkgo Bioworks update 2022 partnership - MSN
Ginkgo outlines $250M cost reduction target and tools expansion in Q1 2025 update - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - simplywall.st
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Acquired by Barclays PLC - Defense World
Ginkgo Bioworks Holdings, Inc. (DNA): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - MSN
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (NYSE: DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Cla - ACCESS Newswire
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Stock Titan
GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (NYSE:DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Cla - ACCESS Newswire
Scientists Discover Bacteria That Breathes Electricity — A Game-Changer for Green Energy - Securities.io
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
0.59%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):